Zavzpret (specific orphan drug)

Zavzpret (zavegepant) is a medication approved to treat acute migraine attacks in adults. It works by blocking a protein called calcitonin gene-related peptide (CGRP), which is involved in causing migraines. Unlike some other migraine medications, Zavzpret is a nasal spray, providing quick relief without the need for injections or oral medication. As an orphan drug, it may be designated for specific patient populations with limited treatment options. It’s important to use under medical supervision, especially since it’s relatively new and may have limited data on long-term safety.